comparemela.com

Latest Breaking News On - Pharma stock down - Page 1 : comparemela.com

Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Down 68.1% in May

Silo Pharma, Inc. (NASDAQ:SILO – Get Free Report) was the target of a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 34,200 shares, a decline of 68.1% from the May 15th total of 107,200 shares. Approximately 1.0% of the shares of the company are […]

Forefront Analytics LLC Grows Stake in Athira Pharma, Inc. (NASDAQ:ATHA)

Forefront Analytics LLC grew its holdings in shares of Athira Pharma, Inc. (NASDAQ:ATHA – Free Report) by 43.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 29,765 shares of the company’s stock after purchasing an additional 8,955 shares during the […]

Athira Pharma, Inc. (NASDAQ:ATHA) Sees Large Drop in Short Interest

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the recipient of a large drop in short interest in May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an […]

Athira Pharma, Inc. (NASDAQ:ATHA) Short Interest Down 12.1% in May

Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) was the target of a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 923,300 shares, a drop of 12.1% from the April 30th total of 1,050,000 shares. Based on an average daily trading volume, of 309,500 […]

China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Tuesday morning. The brokerage issued a hold rating on the stock. China Pharma Stock Down 4.3 % China Pharma stock opened at $0.32 on Tuesday. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.33 […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.